Sezzle Reports Third Quarter 2025 Results GlobeNewswire November 05, 2025 Quarterly GMV rose 58.7% YoY exceeding $1 Billion for the first time Total Revenue increased 67.0% YoY reaching a new quarterly high Net Income Per Diluted Share in the quarter grew 70.5% YoY to $0.75; Adjusted Net Income Per Diluted Share climbed 51.1% YoY to […]
Green Thumb Industries Reports Third Quarter 2025 Results GlobeNewswire November 05, 2025 CHICAGO and VANCOUVER, British Columbia, Nov. 05, 2025 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today reported its financial results for
Matrix Service Company Reports Fiscal Year 2026 First Quarter Results; Reaffirms Fiscal 2026 Revenue Guidance GlobeNewswire November 05, 2025 TULSA, Okla., Nov. 05, 2025 (GLOBE NEWSWIRE) — Matrix Service Company (Nasdaq: MTRX), a leading provider of engineering and construction services to the energy and industrial markets, today announced results for the first quarter of fiscal
PacBio Announces Third Quarter 2025 Financial Results GlobeNewswire November 05, 2025 MENLO PARK, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2025. Third quarter results: Q3 2025 Q3 2024 Revenue $38.4 million $40.0 million Instrument revenue $11.3 million $16.8 million Consumable revenue $21.3
HighPeak Energy, Inc. Announces Third Quarter 2025 Financial and Operating Results and Recent Management Changes GlobeNewswire November 05, 2025 FORT WORTH, Texas, Nov. 05, 2025 (GLOBE NEWSWIRE) — HighPeak Energy, Inc. (“HighPeak” or the “Company”) (NASDAQ: HPK) today announced financial and operating results for the quarter ended September 30, 2025, and recent management changes. HighlightsThird
Revolution Medicines Reports Third Quarter 2025 Financial Results and Update on Corporate Progress GlobeNewswire November 05, 2025 Company is winding down global enrollment for the RASolute 302 clinical trial studying daraxonrasib in patients with previously treated PDAC and remains on track for data readout in 2026 Company has initiated RASolute 304, a Phase 3 clinical
SOLITRON DEVICES, INC. ANNOUNCES FISCAL 2026 THIRD QUARTER TO DATE BOOKINGS OF $13.8 MILLION GlobeNewswire November 05, 2025 WEST PALM BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) — Solitron Devices, Inc. (OTC Pink: SODI) (“Solitron” or the “Company”) is pleased to announce the Company has record breaking bookings for fiscal 2026 third quarter which have
— HEPLISAV-B® quarterly net product revenue of $90 million, a 13% YoY increase; reiterates full year 2025 HEPLISAV-B® net product revenue guidance range of $315 to $325 million — Board of Directors authorizes new $100 million share repurchase program — Positivetopline Phase 1/2 shingles vaccine trial data presented in late-breaker session at IDWeek — Enters
Posts record annual cash flow; Strategic focus positions company for durable growth — Solid execution in FY'25 — Constant currencyARR growth of 8.5% — Record operating and free cash flow, growth of 16% — Strategic focus on delivering Intelligent Product Lifecycle vision with divestiture ofKepware industrial connectivity and ThingWorx Internet of Things (IoT) businesses —
Total Revenues of $1.29B, 19 Consecutive Quarters of Cloud Organic Growth Delivers Net Income Margin of 11%, Robust Adjusted EBITDA Margin of 36.3% GAAP EPS of $0.58, Non-GAAP EPS of $1.05 Fiscal 2026 First Quarter Highlights(in millions)(1)Total Cloud Profitability EPS Cash FlowsRevenues Revenues Net Income A-EBITDA GAAP Non-GAAP Operating Free Cash Flows$1,288 $485 $147 $467